Modelos animais para doenças neuromusculares humanas
DOI:
https://doi.org/10.34024/rnc.2006.v14.8770Palavras-chave:
SuplementoResumo
.
Métricas
Referências
Allamand V, Campbell KP. Animal models for muscular dystrophy: valuable tools for the development of therapies. Human Mol Genet 2000; 9:2459-2467.
Barone V, Bertocchini F, Bottinelli R, Protasi F, Allen PD, Franzini Armstrong C, et al. Contractile impairment and structural alterations of skeletal muscles from knockout mice lacking type 1 and type 3 ryanodine receptors. FEBS Lett 1998; 422:160-164.
Cooper BJ, Winand NJ, Stedman H, Valentine BA, Hoffman EP, Kunkel LM, et al. The homologue of the Duchenne locus is defective in X-linked muscular dystrophy of dogs. Nature 1988; 334: 154-156.
Drachman DB, Frank K, Dykes-Hoberg M, Teismann P, Almer G, Przedborski S, et al. Cyclooxygenase 2 inhibition protects motor neurons and prolongs survival in a transgenic mouse model of ALS. Ann. Neurol 2002; 52: 771 778.
Fujii J, Otsu K, Zorzato F, de Leon S, Khanna VK, Weiler JE, et al. Identification of a mutation in porcine ryanodine receptor associated with malignant hyperthermia. Science 1991; 253: 448-451.
Gussoni E, Soneoka Y, Strickland CD, Buzney EA, Khan MK, Flint AF, et al. Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature 1999; 401: 390-394.
Pastoret C, Sebille A. Mdx mice show progressive weakness and muscle deterioration with age. J Neurol Sci 1995; 129: 97-105.
Vainzof M, Yamamoto LU, Gouveia TLF, Zatz M. The contribution of protein analysis in the diagnosis of neuromuscular diseases. In: Burgess VN, Trends in Muscular Dystrophy Research. USA: Nova Publisher, 2005.
Wong PC, Pardo CA, Borchelt DR, Lee MK, Copeland NG, Jenkins NA, et al. An adverse property of familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 1995; 14:1105-1116.
